Tag: biomedical
-
Large-Scale Antibody Screening Device in Development
A system to quickly screen for human antibodies that neutralize SARS-CoV-2 or other infectious viruses is being developed at Texas A&M University.
-
Fix Discovered for Gene Therapy Virus Delivery
Researchers in France and the U.S. discovered a bacterial enzyme that blocks immune reactions to otherwise benign viruses that deliver gene therapies.
-
Biotechs Apply Crispr Gene-Editing for Hemophilia
A treatment for the blood disease hemophilia and other inherited disorders are being developed with the gene-editing technology Crispr in a biotechnology deal.
-
Covid-19 Antibody Therapy Trial Underway
A clinical trial of neutralizing antibodies to treat Covid-19 infections began testing the therapy with hospitalized patients in New York and Los Angeles.
-
Infographic – Major Cities Far Short of Herd Immunity
The data show in major American and European cities, as well as Wuhan, China, the percentage of the population with antibodies against the coronavirus.
-
Home-Based Cancer Care Boosts Outcomes, Cuts Costs
An evaluation of a two year-old home care service for cancer patients shows the program reduces chances of later hospital visits and lowers overall patient costs.
-
NIH Funds Light-Aided Gene Therapy for Eye Disease
A company creating a gene therapy for age-related macular degeneration activated with near-infrared rays received an NIH grant to advance its technology.
-
Drug Added to Covid-19 Lung Disease Trial
A clinical trial evaluating numerous therapies for a serious lung complication of Covid-19 infections is adding a drug to treat glaucoma to the study.
-
Drug Maker Licenses Low-Dose Vaccine Patch
The pharmaceutical company Merck is licensing a microneedle patch device that delivers vaccines with a small fraction of the dose normally needed by syringes.
-
Health Research Commercialization Company Launched
University of Michigan and health care investor Deerfield Management are creating a new enterprise to bring promising academic life science research to market.